The FDA's expert panel on vaccines met last week (Thursday, January 26, 2023) to discuss the future use of the bivalent COVID shot, signaling the start of the FDA's pivot to a longer-term immunization strategy. This is an important first step in a process that could result in millions of Americans receiving an annual Covid booster, similar to the flu vaccine. Any such changes will require more discussion and decisions, but the FDA appears to be shifting from responding to the pandemic's acute phase to a longer-term norm. Dr. Suzanne Judd, Director of the Lister Hill Center for Health Policy and a Professor in the School of Public Health at the University of Alabama at Birmingham, joined the podcast to discuss these topics and the future of COVID-19 vaccinations.